schliessen

Filtern

 

Bibliotheken

Cover Image

Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review

Highlights ► Reviews the economic benefits of adult and childhood vaccines in developing countries. ► Identified 108 articles from 51 countries covering 23 vaccines. ► 44 articles reported cost per disability-adjusted life years (DALY) averted. ► Vaccines cost less than $100 ($500) per DALY averted... Full description

Journal Title: Vaccine 2012, Vol.31 (1), p.96-108
Main Author: Ozawa, Sachiko
Other Authors: Mirelman, Andrew , Stack, Meghan L , Walker, Damian G , Levine, Orin S
Format: Electronic Article Electronic Article
Language: English
Subjects:
Allergy and Immunology
Animal vaccines
Applied microbiology
Benefits
Biological and medical sciences
Children & youth
Cognition & reasoning
Cost control
Cost-Benefit Analysis
Cost-effectiveness
DALY
Data processing
Databases
Demography
Developing countries
Developing Countries - economics
Economic aspects
Economic evaluation
Economic models
Economics
Fundamental and applied biological sciences. Psychology
GDP
Gross Domestic Product
Hepatitis
Households
Humans
Illnesses
Influenza
Life expectancy
Literature reviews
Low income groups
Measles
Microbiology
Morbidity
Mortality
Population
Productivity
Public health
Quality-Adjusted Life Years
Reviews
Studies
Systematic review
Tropical diseases
Vaccination - economics
Vaccine
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Viruses
Willingness to pay
Quelle: Alma/SFX Local Collection
Publisher: Kidlington: Elsevier Ltd
ID: ISSN: 0264-410X
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_1272738709
title: Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review
format: Article
creator:
  • Ozawa, Sachiko
  • Mirelman, Andrew
  • Stack, Meghan L
  • Walker, Damian G
  • Levine, Orin S
subjects:
  • Allergy and Immunology
  • Animal vaccines
  • Applied microbiology
  • Benefits
  • Biological and medical sciences
  • Children & youth
  • Cognition & reasoning
  • Cost control
  • Cost-Benefit Analysis
  • Cost-effectiveness
  • DALY
  • Data processing
  • Databases
  • Demography
  • Developing countries
  • Developing Countries - economics
  • Economic aspects
  • Economic evaluation
  • Economic models
  • Economics
  • Fundamental and applied biological sciences. Psychology
  • GDP
  • Gross Domestic Product
  • Hepatitis
  • Households
  • Humans
  • Illnesses
  • Influenza
  • Life expectancy
  • Literature reviews
  • Low income groups
  • Measles
  • Microbiology
  • Morbidity
  • Mortality
  • Population
  • Productivity
  • Public health
  • Quality-Adjusted Life Years
  • Reviews
  • Studies
  • Systematic review
  • Tropical diseases
  • Vaccination - economics
  • Vaccine
  • Vaccines
  • Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
  • Viruses
  • Willingness to pay
ispartof: Vaccine, 2012, Vol.31 (1), p.96-108
description: Highlights ► Reviews the economic benefits of adult and childhood vaccines in developing countries. ► Identified 108 articles from 51 countries covering 23 vaccines. ► 44 articles reported cost per disability-adjusted life years (DALY) averted. ► Vaccines cost less than $100 ($500) per DALY averted in 52% (77%) of articles. ► Few studies measure the long-term and societal economic benefits from vaccination.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0264-410X
fulltext: fulltext
issn:
  • 0264-410X
  • 1873-2518
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.6740987
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_1272738709
sourceformatXML
sourcesystemPC
galeidA310717249
sourcerecordidA310717249
originalsourceidFETCH-LOGICAL-c540t-482e6e80c1e25ea206e5f25d112d4b40f3fa0c39b4474b4a0243e781ac16b3e53
addsrcrecordideNqNkk2LFDEQhhtR3HH1JygNInjpMZWPTo-CMgx-wYIHFbyFTLoiGbuTNemeZf696enRhbms5BBSPPWmqt4qiqdAlkCgfrVb7rUxzuOSEqDLY5jdKxbQSFZRAc39YkFozSsO5MdF8SilHSFEMFg9LC4oA04ZkYui34Q0VGgtmsHt0WNKpfZtiSb40DtTbnPMuiGVwZanH1PpfNmFm-pI9q5tO6ycN6HH0oTRD9Fhel2uy3RIA_Z6yDIR9w5vHhcPrO4SPjndl8X3D--_bT5VV18-ft6sryojOBkq3lCssSEGkArUlNQoLBUtAG35lhPLrCaGrbacy_zWhHKGsgFtoN4yFOyyeDnrXsfwe8Q0qN4lg12nPYYxKaCSStZIsvoPlEIjgPEJfX6G7sIYfW5EQU1F04AUNFPLmfqpO1TO2zBEbfJpMc8zTNPM8TUDIkHSo6yYE0wMKUW06jq6XseDAqImr9VOnSavJq_nMMt5z07ljNse239Zf83NwIsToJPRnY3aG5duudw-ENFk7s1ZAcYN2bWQndSuu7OMd3M2ZkOzyVEl49AbbF3MS6Xa4O5UeHumYDrnXS75Fx4w3Q5ZJaqI-jqt9bTVkEWErFfsD26s8VI
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid1625881752
display
typearticle
titleCost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review
sourceAlma/SFX Local Collection
creatorOzawa, Sachiko ; Mirelman, Andrew ; Stack, Meghan L ; Walker, Damian G ; Levine, Orin S
creatorcontribOzawa, Sachiko ; Mirelman, Andrew ; Stack, Meghan L ; Walker, Damian G ; Levine, Orin S
descriptionHighlights ► Reviews the economic benefits of adult and childhood vaccines in developing countries. ► Identified 108 articles from 51 countries covering 23 vaccines. ► 44 articles reported cost per disability-adjusted life years (DALY) averted. ► Vaccines cost less than $100 ($500) per DALY averted in 52% (77%) of articles. ► Few studies measure the long-term and societal economic benefits from vaccination.
identifier
0ISSN: 0264-410X
1EISSN: 1873-2518
2DOI: 10.1016/j.vaccine.2012.10.103
3PMID: 23142307
4CODEN: VACCDE
languageeng
publisherKidlington: Elsevier Ltd
subjectAllergy and Immunology ; Animal vaccines ; Applied microbiology ; Benefits ; Biological and medical sciences ; Children & youth ; Cognition & reasoning ; Cost control ; Cost-Benefit Analysis ; Cost-effectiveness ; DALY ; Data processing ; Databases ; Demography ; Developing countries ; Developing Countries - economics ; Economic aspects ; Economic evaluation ; Economic models ; Economics ; Fundamental and applied biological sciences. Psychology ; GDP ; Gross Domestic Product ; Hepatitis ; Households ; Humans ; Illnesses ; Influenza ; Life expectancy ; Literature reviews ; Low income groups ; Measles ; Microbiology ; Morbidity ; Mortality ; Population ; Productivity ; Public health ; Quality-Adjusted Life Years ; Reviews ; Studies ; Systematic review ; Tropical diseases ; Vaccination - economics ; Vaccine ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Viruses ; Willingness to pay
ispartofVaccine, 2012, Vol.31 (1), p.96-108
rights
0Elsevier Ltd
12012 Elsevier Ltd
22014 INIST-CNRS
3Copyright © 2012 Elsevier Ltd. All rights reserved.
4COPYRIGHT 2012 Elsevier B.V.
5Copyright Elsevier Limited Dec 17, 2012
lds50peer_reviewed
citedbyFETCH-LOGICAL-c540t-482e6e80c1e25ea206e5f25d112d4b40f3fa0c39b4474b4a0243e781ac16b3e53
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27091058$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23142307$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Ozawa, Sachiko
1Mirelman, Andrew
2Stack, Meghan L
3Walker, Damian G
4Levine, Orin S
title
0Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review
1Vaccine
addtitleVaccine
descriptionHighlights ► Reviews the economic benefits of adult and childhood vaccines in developing countries. ► Identified 108 articles from 51 countries covering 23 vaccines. ► 44 articles reported cost per disability-adjusted life years (DALY) averted. ► Vaccines cost less than $100 ($500) per DALY averted in 52% (77%) of articles. ► Few studies measure the long-term and societal economic benefits from vaccination.
subject
0Allergy and Immunology
1Animal vaccines
2Applied microbiology
3Benefits
4Biological and medical sciences
5Children & youth
6Cognition & reasoning
7Cost control
8Cost-Benefit Analysis
9Cost-effectiveness
10DALY
11Data processing
12Databases
13Demography
14Developing countries
15Developing Countries - economics
16Economic aspects
17Economic evaluation
18Economic models
19Economics
20Fundamental and applied biological sciences. Psychology
21GDP
22Gross Domestic Product
23Hepatitis
24Households
25Humans
26Illnesses
27Influenza
28Life expectancy
29Literature reviews
30Low income groups
31Measles
32Microbiology
33Morbidity
34Mortality
35Population
36Productivity
37Public health
38Quality-Adjusted Life Years
39Reviews
40Studies
41Systematic review
42Tropical diseases
43Vaccination - economics
44Vaccine
45Vaccines
46Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
47Viruses
48Willingness to pay
issn
00264-410X
11873-2518
fulltexttrue
rsrctypearticle
creationdate2012
recordtypearticle
recordideNqNkk2LFDEQhhtR3HH1JygNInjpMZWPTo-CMgx-wYIHFbyFTLoiGbuTNemeZf696enRhbms5BBSPPWmqt4qiqdAlkCgfrVb7rUxzuOSEqDLY5jdKxbQSFZRAc39YkFozSsO5MdF8SilHSFEMFg9LC4oA04ZkYui34Q0VGgtmsHt0WNKpfZtiSb40DtTbnPMuiGVwZanH1PpfNmFm-pI9q5tO6ycN6HH0oTRD9Fhel2uy3RIA_Z6yDIR9w5vHhcPrO4SPjndl8X3D--_bT5VV18-ft6sryojOBkq3lCssSEGkArUlNQoLBUtAG35lhPLrCaGrbacy_zWhHKGsgFtoN4yFOyyeDnrXsfwe8Q0qN4lg12nPYYxKaCSStZIsvoPlEIjgPEJfX6G7sIYfW5EQU1F04AUNFPLmfqpO1TO2zBEbfJpMc8zTNPM8TUDIkHSo6yYE0wMKUW06jq6XseDAqImr9VOnSavJq_nMMt5z07ljNse239Zf83NwIsToJPRnY3aG5duudw-ENFk7s1ZAcYN2bWQndSuu7OMd3M2ZkOzyVEl49AbbF3MS6Xa4O5UeHumYDrnXS75Fx4w3Q5ZJaqI-jqt9bTVkEWErFfsD26s8VI
startdate2012
enddate2012
creator
0Ozawa, Sachiko
1Mirelman, Andrew
2Stack, Meghan L
3Walker, Damian G
4Levine, Orin S
general
0Elsevier Ltd
1Elsevier
2Elsevier B.V
3Elsevier Limited
scope
0IQODW
1CGR
2CUY
3CVF
4ECM
5EIF
6NPM
7AAYXX
8CITATION
9BSHEE
103V.
117QL
127RV
137T2
147T5
157U9
167X7
177XB
1888C
1988E
208AO
218C1
228FE
238FH
248FI
258FJ
268FK
278G5
28ABUWG
29AZQEC
30BBNVY
31BENPR
32BHPHI
33C1K
34DWQXO
35FYUFA
36GHDGH
37GNUQQ
38GUQSH
39H94
40HCIFZ
41K9-
42K9.
43KB0
44LK8
45M0R
46M0S
47M0T
48M1P
49M2O
50M7N
51M7P
52MBDVC
53NAPCQ
54PQEST
55PQQKQ
56PQUKI
57Q9U
587X8
sort
creationdate2012
titleCost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review
authorOzawa, Sachiko ; Mirelman, Andrew ; Stack, Meghan L ; Walker, Damian G ; Levine, Orin S
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c540t-482e6e80c1e25ea206e5f25d112d4b40f3fa0c39b4474b4a0243e781ac16b3e53
rsrctypearticles
prefilterarticles
languageeng
creationdate2012
topic
0Allergy and Immunology
1Animal vaccines
2Applied microbiology
3Benefits
4Biological and medical sciences
5Children & youth
6Cognition & reasoning
7Cost control
8Cost-Benefit Analysis
9Cost-effectiveness
10DALY
11Data processing
12Databases
13Demography
14Developing countries
15Developing Countries - economics
16Economic aspects
17Economic evaluation
18Economic models
19Economics
20Fundamental and applied biological sciences. Psychology
21GDP
22Gross Domestic Product
23Hepatitis
24Households
25Humans
26Illnesses
27Influenza
28Life expectancy
29Literature reviews
30Low income groups
31Measles
32Microbiology
33Morbidity
34Mortality
35Population
36Productivity
37Public health
38Quality-Adjusted Life Years
39Reviews
40Studies
41Systematic review
42Tropical diseases
43Vaccination - economics
44Vaccine
45Vaccines
46Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
47Viruses
48Willingness to pay
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Ozawa, Sachiko
1Mirelman, Andrew
2Stack, Meghan L
3Walker, Damian G
4Levine, Orin S
collection
0Pascal-Francis
1Medline
2MEDLINE
3MEDLINE (Ovid)
4MEDLINE
5MEDLINE
6PubMed
7CrossRef
8Academic OneFile (A&I only)
9ProQuest Central (Corporate)
10Bacteriology Abstracts (Microbiology B)
11Nursing & Allied Health Database
12Health and Safety Science Abstracts (Full archive)
13Immunology Abstracts
14Virology and AIDS Abstracts
15Health & Medical Collection
16ProQuest Central (purchase pre-March 2016)
17Healthcare Administration Database (Alumni)
18Medical Database (Alumni Edition)
19ProQuest Pharma Collection
20Public Health Database
21ProQuest SciTech Collection
22ProQuest Natural Science Collection
23Hospital Premium Collection
24Hospital Premium Collection (Alumni Edition)
25ProQuest Central (Alumni) (purchase pre-March 2016)
26Research Library (Alumni Edition)
27ProQuest Central (Alumni Edition)
28ProQuest Central Essentials
29Biological Science Collection
30ProQuest Central
31Natural Science Collection
32Environmental Sciences and Pollution Management
33ProQuest Central Korea
34Health Research Premium Collection
35Health Research Premium Collection (Alumni)
36ProQuest Central Student
37Research Library Prep
38AIDS and Cancer Research Abstracts
39SciTech Premium Collection
40Consumer Health Database (Alumni Edition)
41ProQuest Health & Medical Complete (Alumni)
42Nursing & Allied Health Database (Alumni Edition)
43ProQuest Biological Science Collection
44Consumer Health Database
45Health & Medical Collection (Alumni Edition)
46Healthcare Administration Database
47Medical Database
48Research Library
49Algology Mycology and Protozoology Abstracts (Microbiology C)
50Biological Science Database
51Research Library (Corporate)
52Nursing & Allied Health Premium
53ProQuest One Academic Eastern Edition
54ProQuest One Academic
55ProQuest One Academic UKI Edition
56ProQuest Central Basic
57MEDLINE - Academic
jtitleVaccine
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Ozawa, Sachiko
1Mirelman, Andrew
2Stack, Meghan L
3Walker, Damian G
4Levine, Orin S
formatjournal
genrearticle
ristypeJOUR
atitleCost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review
jtitleVaccine
addtitleVaccine
date2012
risdate2012
volume31
issue1
spage96
epage108
pages96-108
issn0264-410X
eissn1873-2518
codenVACCDE
abstractHighlights ► Reviews the economic benefits of adult and childhood vaccines in developing countries. ► Identified 108 articles from 51 countries covering 23 vaccines. ► 44 articles reported cost per disability-adjusted life years (DALY) averted. ► Vaccines cost less than $100 ($500) per DALY averted in 52% (77%) of articles. ► Few studies measure the long-term and societal economic benefits from vaccination.
copKidlington
pubElsevier Ltd
pmid23142307
doi10.1016/j.vaccine.2012.10.103